Dissecting the shared genetic basis of migraine and mental disorders using novel statistical tools.
bipolar disorder
depression
genetics
migraine
schizophrenia
Journal
Brain : a journal of neurology
ISSN: 1460-2156
Titre abrégé: Brain
Pays: England
ID NLM: 0372537
Informations de publication
Date de publication:
29 03 2022
29 03 2022
Historique:
received:
03
03
2021
revised:
18
05
2021
accepted:
21
06
2021
pubmed:
18
7
2021
medline:
2
4
2022
entrez:
17
7
2021
Statut:
ppublish
Résumé
Migraine is three times more prevalent in people with bipolar disorder or depression. The relationship between schizophrenia and migraine is less certain although glutamatergic and serotonergic neurotransmission are implicated in both. A shared genetic basis to migraine and mental disorders has been suggested but previous studies have reported weak or non-significant genetic correlations and five shared risk loci. Using the largest samples to date and novel statistical tools, we aimed to determine the extent to which migraine's polygenic architecture overlaps with bipolar disorder, depression and schizophrenia beyond genetic correlation, and to identify shared genetic loci. Summary statistics from genome-wide association studies were acquired from large-scale consortia for migraine (n cases = 59 674; n controls = 316 078), bipolar disorder (n cases = 20 352; n controls = 31 358), depression (n cases = 170 756; n controls = 328 443) and schizophrenia (n cases = 40 675, n controls = 64 643). We applied the bivariate causal mixture model to estimate the number of disorder-influencing variants shared between migraine and each mental disorder, and the conditional/conjunctional false discovery rate method to identify shared loci. Loci were functionally characterized to provide biological insights. Univariate MiXeR analysis revealed that migraine was substantially less polygenic (2.8 K disorder-influencing variants) compared to mental disorders (8100-12 300 disorder-influencing variants). Bivariate analysis estimated that 800 (SD = 300), 2100 (SD = 100) and 2300 (SD = 300) variants were shared between bipolar disorder, depression and schizophrenia, respectively. There was also extensive overlap with intelligence (1800, SD = 300) and educational attainment (2100, SD = 300) but not height (1000, SD = 100). We next identified 14 loci jointly associated with migraine and depression and 36 loci jointly associated with migraine and schizophrenia, with evidence of consistent genetic effects in independent samples. No loci were associated with migraine and bipolar disorder. Functional annotation mapped 37 and 298 genes to migraine and each of depression and schizophrenia, respectively, including several novel putative migraine genes such as L3MBTL2, CACNB2 and SLC9B1. Gene-set analysis identified several putative gene sets enriched with mapped genes including transmembrane transport in migraine and schizophrenia. Most migraine-influencing variants were predicted to influence depression and schizophrenia, although a minority of mental disorder-influencing variants were shared with migraine due to the difference in polygenicity. Similar overlap with other brain-related phenotypes suggests this represents a pool of 'pleiotropic' variants that influence vulnerability to diverse brain-related disorders and traits. We also identified specific loci shared between migraine and each of depression and schizophrenia, implicating shared molecular mechanisms and highlighting candidate migraine genes for experimental validation.
Identifiants
pubmed: 34273149
pii: 6323359
doi: 10.1093/brain/awab267
pmc: PMC8967089
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
142-153Subventions
Organisme : NIBIB NIH HHS
ID : R01 EB000790
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS057198
Pays : United States
Investigateurs
Amy E Martinsen
(AE)
Anne Heidi Skogholt
(AH)
Ben Brumpton
(B)
Cristen J Willer
(CJ)
Erling Tronvik
(E)
Espen Saxhaug Kristoffersen
(ES)
John-Anker Zwart
(JA)
Jonas Bille Nielsen
(JB)
Knut Hagen
(K)
Kristian Bernhard Nilsen
(KB)
Kristian Hveem
(K)
Lars Jacob Stovner
(LJ)
Lars G Fritsche
(LG)
Laurent F Thomas
(LF)
Linda M Pedersen
(LM)
Maiken E Gabrielsen
(ME)
Marianne Bakke Johnsen
(MB)
Marie Udnesseter Lie
(MU)
Oddgeir Holmen
(O)
Sigrid Børte
(S)
Synne Øien Stensland
(SØ)
Wei Zhou
(W)
Informations de copyright
© The Author(s) (2021). Published by Oxford University Press on behalf of the Guarantors of Brain.
Références
Nat Genet. 2015 Mar;47(3):291-5
pubmed: 25642630
Nat Genet. 2018 May;50(5):668-681
pubmed: 29700475
Lancet Neurol. 2018 Feb;17(2):174-182
pubmed: 29229375
Nat Genet. 2017 Jan;49(1):152-156
pubmed: 27918536
Front Psychiatry. 2018 Mar 06;9:65
pubmed: 29559929
Eur Neuropsychopharmacol. 2016 Sep;26(9):1507-1515
pubmed: 27394076
Nat Genet. 2019 Dec;51(12):1670-1678
pubmed: 31740837
J Headache Pain. 2017 Dec;18(1):20
pubmed: 28194570
Brain Sci. 2020 Sep 06;10(9):
pubmed: 32899972
Lancet. 2018 Nov 24;392(10161):2299-2312
pubmed: 30396512
Eur J Hum Genet. 2018 Aug;26(8):1202-1216
pubmed: 29995844
Lancet. 2016 Jul 2;388(10039):86-97
pubmed: 26777917
Int J Epidemiol. 2013 Aug;42(4):968-77
pubmed: 22879362
Drug News Perspect. 2005 May;18(4):262-8
pubmed: 16034483
Gen Hosp Psychiatry. 2013 Sep-Oct;35(5):480-4
pubmed: 23639185
Neurology. 2016 Nov 29;87(22):2370-2374
pubmed: 27807184
Biol Psychiatry. 2021 Jan 1;89(1):20-31
pubmed: 33131714
Mol Neurobiol. 2016 Jul;53(5):2778-2786
pubmed: 25823514
Invest Clin. 2012 Mar;53(1):38-51
pubmed: 22524107
Nat Genet. 2016 Aug;48(8):856-66
pubmed: 27322543
Science. 2018 Jun 22;360(6395):
pubmed: 29930110
Neuropsychopharmacology. 2006 Feb;31(2):431-41
pubmed: 16123739
J Headache Pain. 2019 Jun 21;20(1):72
pubmed: 31226929
Psychiatr Genet. 2019 Oct;29(5):152-159
pubmed: 31464996
Mol Cell Biol. 2010 Jun;30(12):3059-70
pubmed: 20385766
Nat Genet. 2016 Sep;48(9):1031-6
pubmed: 27479909
Transl Psychiatry. 2020 Jun 30;10(1):209
pubmed: 32606422
Cell. 2019 Dec 12;179(7):1469-1482.e11
pubmed: 31835028
Mol Psychiatry. 2020 Apr;25(4):844-853
pubmed: 30610197
Hum Genet. 2020 Jan;139(1):85-94
pubmed: 31520123
Australas Psychiatry. 2017 Aug;25(4):381-384
pubmed: 28747114
Headache. 2003 Oct;43(9):940-9
pubmed: 14511270
Scand J Pain. 2016 Apr;11:136-145
pubmed: 28850455
Mol Psychiatry. 2014 Jan;19(1):20-9
pubmed: 24166406
Cephalalgia. 2001 Nov;21(9):894-9
pubmed: 11903283
PLoS Genet. 2014 Jun 05;10(6):e1004345
pubmed: 24901509
Lancet. 2018 Mar 31;391(10127):1315-1330
pubmed: 29523342
Lancet. 2016 Apr 9;387(10027):1561-1572
pubmed: 26388529
Nat Genet. 2000 May;25(1):25-9
pubmed: 10802651
Nat Rev Neurol. 2020 Jul;16(7):366-379
pubmed: 32528109
Headache. 2014 Apr;54(4):619-39
pubmed: 24697223
Neuron. 2018 May 2;98(3):466-481
pubmed: 29723500
Nat Genet. 2019 Sep;51(9):1339-1348
pubmed: 31427789
Bioinformatics. 2019 Oct 1;35(19):3576-3583
pubmed: 30850848
Nat Protoc. 2016 Oct;11(10):1889-907
pubmed: 27606777
Psychiatry Res. 2019 Aug;278:180-187
pubmed: 31207455
Brain. 2019 Jul 1;142(7):2149-2164
pubmed: 31099820
Nat Commun. 2020 Jul 14;11(1):3512
pubmed: 32665545
Nature. 2014 Apr 10;508(7495):199-206
pubmed: 24695229
Biol Psychiatry. 2021 Feb 1;89(3):227-235
pubmed: 32201043
Nucleic Acids Res. 2021 Jan 8;49(D1):D325-D334
pubmed: 33290552
Neurology. 2003 Apr 22;60(8):1308-12
pubmed: 12707434
PLoS One. 2017 Sep 28;12(9):e0185663
pubmed: 28957430
Nat Commun. 2017 Nov 28;8(1):1826
pubmed: 29184056
Cell. 2013 Aug 1;154(3):518-29
pubmed: 23911319
Cell. 2017 Jun 15;169(7):1177-1186
pubmed: 28622505
Eur Neuropsychopharmacol. 2005 Aug;15(4):425-34
pubmed: 15935623
Nat Commun. 2019 Jun 3;10(1):2417
pubmed: 31160569
Proc Natl Acad Sci U S A. 2007 Jun 12;104(24):10164-9
pubmed: 17553960
Biol Psychiatry. 2018 Mar 15;83(6):492-498
pubmed: 28987712
Nat Genet. 2018 Mar;50(3):381-389
pubmed: 29483656
PLoS Genet. 2013 Apr;9(4):e1003455
pubmed: 23637625
Biol Psychiatry. 2020 Jun 15;87(12):1052-1062
pubmed: 32061372
Nucleic Acids Res. 2019 Jan 8;47(D1):D886-D894
pubmed: 30371827
Nat Neurosci. 2019 Mar;22(3):343-352
pubmed: 30718901
Nat Genet. 2018 Aug;50(8):1112-1121
pubmed: 30038396
Neurol Sci. 2009 May;30 Suppl 1:S61-5
pubmed: 19415428
Nat Genet. 2019 May;51(5):793-803
pubmed: 31043756
J Neurol Neurosurg Psychiatry. 2016 Jul;87(7):741-9
pubmed: 26733600
Am J Psychiatry. 2018 Nov 1;175(11):1137-1144
pubmed: 30021458
Nat Genet. 2018 Jul;50(7):912-919
pubmed: 29942086
Bioinformatics. 2017 Mar 1;33(5):762-763
pubmed: 28011779
Cephalalgia. 2010 Sep;30(9):1065-72
pubmed: 20713557
Neuropsychopharmacology. 2018 Oct;43(11):2277-2284
pubmed: 29849055
Headache. 2008 Oct;48(9):1409-10
pubmed: 19006558
PLoS One. 2017 Apr 14;12(4):e0175908
pubmed: 28410431
Nat Commun. 2018 Apr 16;9(1):1470
pubmed: 29662059
Nat Genet. 2018 Feb;50(2):229-237
pubmed: 29292387
Am J Hum Genet. 2013 Feb 7;92(2):197-209
pubmed: 23375658
PLoS Genet. 2020 May 19;16(5):e1008612
pubmed: 32427991
Hum Mol Genet. 2016 Jun 15;25(12):2451-2464
pubmed: 27260404
Transl Psychiatry. 2018 May 24;8(1):105
pubmed: 29799522
Neurology. 2002 May 14;58(9 Suppl 6):S21-6
pubmed: 12011270
Nat Hum Behav. 2021 Jun;5(6):795-801
pubmed: 33462475
J Affect Disord. 2015 Jun 1;178:88-97
pubmed: 25801521
Twin Res. 2003 Oct;6(5):422-31
pubmed: 14624726
PLoS One. 2011;6(6):e20468
pubmed: 21674006